Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours

British Journal of Cancer

Volumn 111, Issue 10, 2014, Pages 2014-2023

  Singh, R R ^a   Patel, K P ^a   Routbort, M J ^a   Aldape, K ^a   Lu, X ^a   Manekia, J ^a   Abraham, R ^a   Reddy, N G ^a   Barkoh, B A ^a   Veliyathu, J ^a   Medeiros, L J ^a   Luthra, R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

copy number variations; Ion Proton; Ion Torrent; mutations; next generation sequencing; solid tumours

Indexed keywords

ALK PROTEIN; APC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN P53; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; DNA; TUMOR PROTEIN;

AMPLICON; ARTICLE; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 8; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA EXTRACTION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MONOSOMY; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLID TUMOR; SOMATIC MUTATION; TUMOR BIOPSY; GENETICS; HIGH THROUGHPUT SEQUENCING; MUTATION; NEOPLASMS; POLYMERASE CHAIN REACTION; PROCEDURES; REPRODUCIBILITY;

DNA; DNA COPY NUMBER VARIATIONS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 84922481680     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.518     Document Type: Article

References (22)

1. Beadling C, Neff TL, Heinrich MC, Rhodes K, Thornton M, Leamon J, Andersen M, Corless CL (2013) Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping. J Mo Diagn 15(2): 171-176
2. Bielinski SJ, Olson JE, Pathak J, Weinshilboum RM, Wang L, Lyke KJ, Ryu E, Targonski PV, Van Norstrand MD, Hathcock MA, Takahashi PY, McCormick JB, Johnson KJ, Maschke KJ, Rohrer Vitek CR, Ellingson MS, Wieben ED, Farrugia G, Morrisette JA, Kruckeberg KJ, Bruflat JK, Peterson LM, Blommel JH, Skierka JM, Ferber MJ, Black JL, Baudhuin LM, Klee EW, Ross JL, Veldhuizen TL, Schultz CG, Caraballo PJ, Freimuth RR, Chute CG, Kullo IJ (2014) Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol. Mayo Clin Proc 89(1): 25-33
3. Bowcock AM (2013) Invited review DNA copy number changes as diagnostic tools for lung cancer. Thorax 69(5): 495-496
4. Dutton-Regester K, Hayward NK (2012) Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy. Adv Pharmacol 65: 399-435
5. Forbes SA, Bhamra G, Bamford S, Dawson E, Kok C, Clements J, Menzies A, Teague JW, Futreal PA, Stratton MR (2008) The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Gen 57: 10.11.1-10.11.26
6. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos AH, Lawrence MS, Cibulskis K, Sivachenko A, Voet D, Saksena G, Stransky N, Onofrio RC, Winckler W, Ardlie K, Wagle N, Wargo J, Chong K, Morton DL, Stemke-Hale K, Chen G, Noble M, Meyerson M, Ladbury JE, Davies MA, Gershenwald JE, Wagner SN, Hoon DS, Schadendorf D, Lander ES, Gabriel SB, Getz G, Garraway LA, Chin L (2012) A landscape of driver mutations in melanoma. Cell 150(2): 251-263
7. Li T, Kung HJ, Mack PC, Gandara DR (2013) Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol 31(8): 1039-1049
8. Liang H, Kim YH (2013) Identifying molecular drivers of gastric cancer through next-generation sequencing. Cancer Lett 340(2): 241-246
9. Luthra R, Patel KP, Reddy NG, Haghshenas V, Routbort MJ, Harmon MA, Barkoh BA, Kanagal-Shamanna R, Ravandi F, Cortes JE, Kantarjian HM, Medeiros LJ, Singh RR (2014) Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring. Haematologica 99(3): 465-473
10. Martelli MP, Sportoletti P, Tiacci E, Martelli MF, Falini B (2013) Mutational landscape of AML with normal cytogenetics: biological and clinical implications. Blood Rev 27(1): 13-22
11. Mwenifumbo JC, Marra MA (2013) Cancer genome-sequencing study design. Nat Rev Genet 14(5): 321-332
12. Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17(8): 857-872
13. Roberts NJ, Klein AP (2013) Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer. Cancer Lett 340(2): 227-233
14. Ross JS, Cronin M (2011) Whole cancer genome sequencing by nextgeneration methods. Am J Clin Pathol 136(4): 527-539
15. Ross JS, Wang K, Rand JV, Sheehan CE, Jennings TA, Al-Rohil RN, Otto GA, Curran JC, Palmer G, Downing SR, Yelensky R, Lipson D, Balasubramanian S, Garcia L, Mahoney K, Ali SM, Miller VA, Stephens PJ (2014) Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies. Am J Surg Pathol 38(2): 235-238
16. Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, Leamon JH, Johnson K, Milgrew MJ, Edwards M, Hoon J, Simons JF, Marran D, Myers JW, Davidson JF, Branting A, Nobile JR, Puc BP, Light D, Clark TA, Huber M, Branciforte JT, Stoner IB, Cawley SE, LyonsM, Fu Y, Homer N, Sedova M, Miao X, Reed B, Sabina J, Feierstein E, Schorn M, Alanjary M, Dimalanta E, Dressman D, Kasinskas R, Sokolsky T, Fidanza JA, Namsaraev E, McKernan KJ, Williams A, Roth GT, Bustillo J (2011) An integrated semiconductor device enabling non-optical genome sequencing. Nature 475(7356): 348-352
17. Singh RR, Patel KP, Routbort MJ, Reddy N, Barkoh B, Handal B, Kanagal-Shamanna R, Greaves WO, Medeiros LJ, Aldape K, Luthra R (2013) Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. J Mol Diagn 15(5): 607-622
18. Spencer DH, Sehn JK, Abel HJ, Watson MA, Pfeifer JD, Duncavage EJ (2013) Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens. J Mol Diagn 15(5): 623-633
19. Thorvaldsdottir H, Robinson JT, Mesirov JP (2012) Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14(2): 178-192
20. Tuna M, Amos CI (2013) Genomic sequencing in cancer. Cancer Lett 340(2): 161-170
21. Walter MJ, Payton JE, Ries RE, Shannon WD, Deshmukh H, Zhao Y, Baty J, Heath S, Westervelt P, Watson MA, Tomasson MH, Nagarajan R, O'Gara BP, Bloomfield CD, Mrozek K, Selzer RR, Richmond TA, Kitzman J, Geoghegan J, Eis PS, Maupin R, Fulton RS, McLellan M, Wilson RK, Mardis ER, Link DC, Graubert TA, DiPersio JF, Ley TJ (2009) Acquired copy number alterations in adult acute myeloid leukemia genomes. Proc Natl Acad Sci USA 106(31): 12950-12955
22. Workman P, Al-Lazikani B, Clarke PA (2013) Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology. Curr Opin Pharmacol 13(4): 486-496